Data layersRaw factsCalculatedModel predictionAI interpretation
Allotment Overview Calculated
Total Subscription Fees vs Public Offering Raise Amount
Total Subscription Fees vs Public Offering Raise Amount
(assuming HKD 100 handling fee per application)
Assuming a handling fee of HKD 100 per valid application, the total handling fees across all valid applications represent the corresponding ratio of the public offering raise amount. These fees are collected by brokers/banks and are payable regardless of whether the application is successful, representing a hidden cost often overlooked by investors in IPO subscriptions.
Subscription Tier Analysis Model prediction
Expected Lots Allotted by Subscription Tier
Pool A applications , Pool B applications . Expected lots allotted = "Approximate percentage of total shares applied for" as stated in the allotment announcement × shares applied ÷ lot size, taken directly from the announcement.
Capital Efficiency by Subscription Tier
Capital efficiency = Expected shares allotted ÷ shares applied × 100, i.e. the original "Approximate percentage of total shares applied for" value from the allotment announcement. The fewer shares applied for, the higher the capital efficiency.
Applicant Distribution by Subscription Tier
The vertical axis uses a logarithmic scale to better observe distribution differences across tiers of varying magnitudes. All four charts share the same x-axis; hover tooltips are synchronized.
Subscription Fee ÷ Allotted Market Value by Tier
Allotted market value = valid applicants × shares applied × (percentage applied for ÷ 100) × offer price; total handling fees = valid applicants × HKD 100; ratio = total fees ÷ allotted market value × 100%. Lower tiers have disproportionately high ratios due to very small allotments; ratios stabilize at higher tiers.
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.
Market Sentiment
丹诺医药IPO获得9015.11倍超额认购，最终中签率仅6.0%，反映出极度狂热的零售情绪。低至3785港元的入场门槛引发散户大规模涌入，冻资效应显著，市场对生物医药板块追捧力度可见一斑。 (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Tier Analysis
甲尾（60000股）预期获配0.1379手，乙头（70000股）预期获配0.14手，两者几乎等同，违背了规模申购边际优势的常规。这种分配模式使得升级到乙组几乎无额外效益，经纪人费用与获配概率严重失衡。 (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Demographics
本次发行未披露认购人地域分布数据，无法评估内地或香港投资者占比。一般超购倍数极高的生物医药股易引多元背景参与，但具体区域集中度无从判断。 (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
About this page
This page shows allotment analysis for Tennor Therap-B (06872): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.
IPOIPO Allotment Results Analysis
